Does the media prefer EW or HSIC?

In the previous week, Henry Schein had 2 more articles in the media than Edwards Lifesciences. MarketBeat recorded 8 mentions for Henry Schein and 6 mentions for Edwards Lifesciences. Henry Schein's average media sentiment score of 0.89 beat Edwards Lifesciences' score of 0.14 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Henry Schein 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AMN or EW?

In the previous week, Edwards Lifesciences had 2 more articles in the media than AMN Healthcare Services. MarketBeat recorded 6 mentions for Edwards Lifesciences and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat Edwards Lifesciences' score of 0.14 indicating that AMN Healthcare Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ABT or EW?

In the previous week, Abbott Laboratories had 15 more articles in the media than Edwards Lifesciences. MarketBeat recorded 21 mentions for Abbott Laboratories and 6 mentions for Edwards Lifesciences. Abbott Laboratories' average media sentiment score of 0.54 beat Edwards Lifesciences' score of 0.14 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 8 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to EW or ISRG?

In the previous week, Intuitive Surgical had 9 more articles in the media than Edwards Lifesciences. MarketBeat recorded 15 mentions for Intuitive Surgical and 6 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 0.64 beat Edwards Lifesciences' score of 0.14 indicating that Intuitive Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Intuitive Surgical 4 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer MDT or EW?

In the previous week, Medtronic had 33 more articles in the media than Edwards Lifesciences. MarketBeat recorded 39 mentions for Medtronic and 6 mentions for Edwards Lifesciences. Medtronic's average media sentiment score of 0.83 beat Edwards Lifesciences' score of 0.14 indicating that Medtronic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medtronic 15 Very Positive mention(s) 13 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Edwards Lifesciences (EW) Competitors

$85.12 -1.20 (-1.38%)

As of 03:09 PM Eastern

Compare

EW vs. HSIC, AMN, ABT, ISRG, and MDT

Should you buy Edwards Lifesciences stock or one of its competitors? Edwards Lifesciences's main competitors and comparable companies include Henry Schein (HSIC), AMN Healthcare Services (AMN), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Medtronic (MDT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Edwards Lifesciences compare to Henry Schein?

Edwards Lifesciences (NYSE:EW) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Edwards Lifesciences has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

Edwards Lifesciences currently has a consensus target price of $100.27, suggesting a potential upside of 18.20%. Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 9.78%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts clearly believe Edwards Lifesciences is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.53

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 0.9% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Henry Schein had 2 more articles in the media than Edwards Lifesciences. MarketBeat recorded 8 mentions for Henry Schein and 6 mentions for Edwards Lifesciences. Henry Schein's average media sentiment score of 0.89 beat Edwards Lifesciences' score of 0.14 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.05	$1.07B	$1.74	48.75
Henry Schein	$13.18B	0.72	$398M	$3.43	24.68

Edwards Lifesciences has a net margin of 15.43% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Henry Schein	2.96%	15.97%	5.56%

Summary

Edwards Lifesciences beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Edwards Lifesciences (NYSE:EW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

In the previous week, Edwards Lifesciences had 2 more articles in the media than AMN Healthcare Services. MarketBeat recorded 6 mentions for Edwards Lifesciences and 4 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat Edwards Lifesciences' score of 0.14 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.1% of AMN Healthcare Services shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Edwards Lifesciences has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$2.73B	0.51	-$95.70M	$2.68	13.38
Edwards Lifesciences	$6.07B	8.05	$1.07B	$1.74	48.75

AMN Healthcare Services has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

AMN Healthcare Services currently has a consensus target price of $36.00, indicating a potential upside of 0.42%. Edwards Lifesciences has a consensus target price of $100.27, indicating a potential upside of 18.20%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Edwards Lifesciences has a net margin of 15.43% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Edwards Lifesciences	15.43%	15.68%	12.05%

Summary

Edwards Lifesciences beats AMN Healthcare Services on 11 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Abbott Laboratories?

Abbott Laboratories (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Abbott Laboratories presently has a consensus target price of $119.50, indicating a potential upside of 22.73%. Edwards Lifesciences has a consensus target price of $100.27, indicating a potential upside of 18.20%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, equities analysts clearly believe Abbott Laboratories is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Abbott Laboratories has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

Abbott Laboratories has higher revenue and earnings than Edwards Lifesciences. Abbott Laboratories is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	3.80	$6.52B	$3.09	31.51
Edwards Lifesciences	$6.07B	8.05	$1.07B	$1.74	48.75

Edwards Lifesciences has a net margin of 15.43% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
Edwards Lifesciences	15.43%	15.68%	12.05%

In the previous week, Abbott Laboratories had 15 more articles in the media than Edwards Lifesciences. MarketBeat recorded 21 mentions for Abbott Laboratories and 6 mentions for Edwards Lifesciences. Abbott Laboratories' average media sentiment score of 0.54 beat Edwards Lifesciences' score of 0.14 indicating that Abbott Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	8 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Edwards Lifesciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Abbott Laboratories beats Edwards Lifesciences on 11 of the 17 factors compared between the two stocks.

How does Edwards Lifesciences compare to Intuitive Surgical?

Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

In the previous week, Intuitive Surgical had 9 more articles in the media than Edwards Lifesciences. MarketBeat recorded 15 mentions for Intuitive Surgical and 6 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 0.64 beat Edwards Lifesciences' score of 0.14 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intuitive Surgical	4 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Edwards Lifesciences presently has a consensus target price of $100.27, suggesting a potential upside of 18.20%. Intuitive Surgical has a consensus target price of $508.68, suggesting a potential upside of 26.96%. Given Intuitive Surgical's higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Intuitive Surgical is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.07B	8.05	$1.07B	$1.74	48.75
Intuitive Surgical	$10.06B	14.06	$2.86B	$8.73	45.89

Intuitive Surgical has a net margin of 28.45% compared to Edwards Lifesciences' net margin of 15.43%. Intuitive Surgical's return on equity of 16.91% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Intuitive Surgical	28.45%	16.91%	14.83%

Edwards Lifesciences has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market.

Summary

Intuitive Surgical beats Edwards Lifesciences on 14 of the 16 factors compared between the two stocks.

How does Edwards Lifesciences compare to Medtronic?

Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

82.1% of Medtronic shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.3% of Medtronic shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Medtronic has higher revenue and earnings than Edwards Lifesciences. Medtronic is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$36.36B	3.04	$4.80B	$4.06	21.30
Edwards Lifesciences	$6.07B	8.05	$1.07B	$1.74	48.75

In the previous week, Medtronic had 33 more articles in the media than Edwards Lifesciences. MarketBeat recorded 39 mentions for Medtronic and 6 mentions for Edwards Lifesciences. Medtronic's average media sentiment score of 0.83 beat Edwards Lifesciences' score of 0.14 indicating that Medtronic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medtronic	15 Very Positive mention(s)	13 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Edwards Lifesciences has a net margin of 15.43% compared to Medtronic's net margin of 13.93%. Edwards Lifesciences' return on equity of 15.68% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medtronic	13.93%	14.78%	7.97%
Edwards Lifesciences	15.43%	15.68%	12.05%

Medtronic currently has a consensus price target of $103.92, indicating a potential upside of 20.18%. Edwards Lifesciences has a consensus price target of $100.27, indicating a potential upside of 18.20%. Given Medtronic's higher probable upside, equities analysts clearly believe Medtronic is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	0 Sell rating(s)	9 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.68
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

Medtronic has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market.

Summary

Medtronic and Edwards Lifesciences tied by winning 8 of the 16 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EW vs. The Competition

Export

Metric	Edwards Lifesciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$48.92B	$5.36B	$7.13B	$22.56B
Dividend Yield	N/A	1.79%	2.52%	3.72%
P/E Ratio	48.83	24.58	273.64	27.53
Price / Sales	8.05	68.16	656.97	21.87
Price / Cash	30.89	32.86	79.75	40.95
Price / Book	4.76	5.62	10.54	4.61
Net Income	$1.07B	$150.14M	$3.50B	$1.08B
7 Day Performance	-1.03%	-2.38%	-2.04%	-1.39%
1 Month Performance	-6.55%	-5.00%	-5.21%	-4.85%
1 Year Performance	11.01%	3.79%	10.28%	4.88%

Edwards Lifesciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EW Edwards Lifesciences	3.7336 of 5 stars	$85.13 -1.4%	$100.27 +17.8%	+11.0%	$48.87B	$6.07B	48.78	16,000
HSIC Henry Schein	3.4064 of 5 stars	$85.99 -0.4%	$92.93 +8.1%	+26.5%	$9.63B	$13.18B	25.07	25,000	Positive News
AMN AMN Healthcare Services	1.2895 of 5 stars	$34.20 -1.0%	$36.00 +5.3%	+86.0%	$1.34B	$2.73B	12.76	2,664
ABT Abbott Laboratories	4.9512 of 5 stars	$100.94 -0.3%	$119.50 +18.4%	-26.1%	$175.27B	$44.33B	32.67	115,000	Trending News
ISRG Intuitive Surgical	4.2178 of 5 stars	$414.79 +2.4%	$508.68 +22.6%	-9.1%	$143.14B	$10.06B	47.51	17,021

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:EW) was last updated on 10/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and MDT

How does Edwards Lifesciences compare to Henry Schein?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Summary

How does Edwards Lifesciences compare to Medtronic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edwards Lifesciences (EW) Competitors

EW vs. HSIC, AMN, ABT, ISRG, and MDT

How does Edwards Lifesciences compare to Henry Schein?

Which has more volatility & risk, EW or HSIC?

Do analysts prefer EW or HSIC?

Do insiders & institutionals hold more shares of EW or HSIC?

Does the media prefer EW or HSIC?

Which has stronger earnings and valuation, EW or HSIC?

Is EW or HSIC more profitable?

Summary

How does Edwards Lifesciences compare to AMN Healthcare Services?

Does the media favor AMN or EW?

Do institutionals & insiders believe in AMN or EW?

Which has stronger valuation & earnings, AMN or EW?

Which has more volatility and risk, AMN or EW?

Do analysts recommend AMN or EW?

Is AMN or EW more profitable?

Summary

How does Edwards Lifesciences compare to Abbott Laboratories?

Do analysts rate ABT or EW?

Which has more risk and volatility, ABT or EW?

Which has better earnings & valuation, ABT or EW?

Is ABT or EW more profitable?

Does the media favor ABT or EW?

Do institutionals and insiders hold more shares of ABT or EW?

Summary

How does Edwards Lifesciences compare to Intuitive Surgical?

Does the media refer more to EW or ISRG?

Do institutionals & insiders have more ownership in EW or ISRG?

Do analysts prefer EW or ISRG?

Which has higher valuation & earnings, EW or ISRG?

Is EW or ISRG more profitable?

Which has more volatility & risk, EW or ISRG?

Summary

How does Edwards Lifesciences compare to Medtronic?

Do insiders & institutionals believe in MDT or EW?

Which has better earnings & valuation, MDT or EW?

Does the media prefer MDT or EW?

Is MDT or EW more profitable?

Do analysts recommend MDT or EW?

Which has more volatility & risk, MDT or EW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EW vs. The Competition

Edwards Lifesciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools